-+ 0.00%
-+ 0.00%
-+ 0.00%

Genedrive Finalizes UK Patient Enrollment for Rapid Pharmacogenetic Test

MT Newswires·08/11/2026 04:25:34
Listen to the news
04:25 AM EDT, 08/11/2026 (MT Newswires) -- Genedrive (GDR.L) said Tuesday it has completed patient recruitment for its PALOH-UK program, with nearly 6,000 babies in neonatal care receiving its rapid MT-RNR1 ID test to help prevent antibiotic-induced hearing loss. The point-of-care pharmacogenetic testing company said clinical cohort analysis is underway, with publication of the findings expected in October. The program is funded by the National Institute for Health and Care Research in collaboration with the UK Government Office for Life Sciences.